recent post

Kolkata scientists identify therapy to help cancer patients overcome resistance to current treatments

October 11, 2024
recent post

Holy Family Hospital in Bandra, Mumbai opens one-stop breast clinic

recent post

360 ONE Asset Management invests in Tamil Nadu-based A4 Hospitals

recent post

Sankara Eye Foundation unveils SAHAI

recent post

Oncologist Dr Raj Nagarkar joins Cambridge Medical Robotics’ Advisory Board

imt Logo cross btn

HCG launches journal on precision oncology

HCG launches journal on precision oncology

The journal aims at building upon the current understanding of cancer in a manner that treats each type of cancer and each patient as a unique case HCG has launched the first edition of the Journal of Precision Oncology. The journal is developed in association with Wolters Kluwer and ATRO – Association for transitional research in oncology. The Journal of Precision Oncology aims at building upon the current understanding of cancer in a manner that treats each type of cancer and each patient as a unique case, such that care strategies can be tailor-made to cater to this uniqueness while adhering to evidence-based practices. It is the official semi-annual publication of HCG, available both online and in print formats. Dr. BS Ajaikumar, Chairman and CEO, Healthcare Global Enterprise said “The launch of the Journal of Precision Oncology will act as a platform for like-minded researchers sharing their experiences in addressing critical issues, exchanging new insights and developments in cancer care. This journal will raise the bar in cancer care and help us work together in optimizing patient outcomes by adding years to their lives”. Dr. Ravi C Nayar, Editor, Journal of Precision Oncology, Department Of Academics, HealthCare Global Enterprises said “We hope this journal and its focus will foster this unique attitude to cancer care in general and individual patient’s betterment in particular. I thank all those who worked tirelessly for this effort.” Dr. Vishal Rao US, Editor and Associate Dean, Department Of Academics, HealthCare Global Enterprises said “The journal intents at redefining the future of oncology and also aims for the cancer moonshot from India. As we observe an occurrence of significant growth in translational oncology and this journal includes important single subject clinical trials, rare responder studies, basic science, translational and clinical research articles, case reports, and brief communications, commentaries, perspectives, and review articles. Each original research article will include a lay summary that will summarize the key issues with the goal of maximising the impact and reach of the research findings”. All spectrums of cancer across India will be covered in the journal which will help in redefining the future of oncology. Experts and like- minded researchers can share their experiences in bringing the best and latest advances in treatment to patient care by submissions for the future issues of the journal.